hims glp-1 news & Hers to offer access to compounded injections for as low as $99/month to first responders HIMS to Introduce Compounded GLP-1
Description
Infographic summarizing GIP as a therapeutic target
With so many therapies available, how do clinicians decide what comes next
Michael Stubblefield is medical director of cancer rehabilitation at the Kessler Institute for Rehabilitation in New Jersey and the national medical director for Select Medicals ReVital Cancer Rehabilitation program
Older adults can lose substantial muscle mass with preserved strength
Owing to its pronounced effects on body-weight reduction, glycemic regulation, and attenuation of systemic inflammation, GLP-1RAs have attracted growing interest as potential modulators of cancer-relevant biological pathways
